PH

Pharvaris NVNASDAQ PHVS Stock Report

Last reporting period 30 Sep, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

1.026

Small

Exchange

XNAS - Nasdaq

PHVS Stock Analysis

PH

Uncovered

Pharvaris NV is uncovered by Eyestock quantitative analysis.

Market cap $B

1.026

Dividend yield

Shares outstanding

33.152 B

Pharvaris NV operates as a clinical-stage biopharmaceutical company. The company is headquartered in Leiden, Zuid-Holland and currently employs 34 full-time employees. The company went IPO on 2021-02-05. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).

View Section: Eyestock Rating